Point72 Middle East FZE’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,599
Closed -$61.7K 1757
2023
Q2
$61.7K Buy
18,599
+7,925
+74% +$23.4K ﹤0.01% 1270
2023
Q1
$22.7K Buy
+10,674
New +$26.4K ﹤0.01% 1408

Other funds holding ORGO

Point72 Middle East FZE's ORGO Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Organogenesis Holdings (ORGO) in Q3 2023, closing a stake of 18,599 shares — an estimated $61.7K sold.

Point72 Middle East FZE first reported a position in ORGO in Q1 2023 and held it in 2 quarters. The position peaked at $61.7K in Q2 2023. 104 funds tracked by Wall St. Rank hold ORGO as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Organogenesis Holdings position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 18,599 Organogenesis Holdings shares in Q3 2023, an estimated $61.7K.
  • Point72 Middle East FZE first reported a position in Organogenesis Holdings in Q1 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Organogenesis Holdings position peaked at $61.7K in Q2 2023.
  • 104 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.